ASLN ASLAN Pharmaceuticals Limited ADRs

ASLAN Pharmaceuticals Ltd is an oncology-focused biotechnology company developing a portfolio of immuno-oncology agents and targeted therapies. Its products include Varlitinib, ASLAN002, ASLAN003, ASLAN004, ASLAN005, and Modybodies. This is an ADR of a company that does not have its stock publicly traded anywhere else in the world.

$4.32  -0.93 (-17.71%)
As of 03/02/2021 15:59:38 EST     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
ADRs
Micro cap
Health Care
Biotechnology
Singapore

05/04/2018
37,990,994
4,090,935
$199,452,719
0.00%
SEC Edgar Online
20-F
04522R101
US04522R1014

Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
0.00
12.80
0.00
327.68%
0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy